Unlock the Editor’s Digest for freeRoula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter.Thanks to…
Another week, another wave of wild threats from US president-elect Donald Trump. On Tuesday, he pledged to “tariff Denmark at…
Six months ago, I laid out my most recent investment thesis on Mondelez (NASDAQ:MDLZ) stock…
Hardline Republican lawmakers vowed to “do everything” in their power to stop a bipartisan deal…
Investment Overview - Why Big Pharma Company Valuations Often Seem To Defy Logic Of all…
The head of Mercedes-Benz has called for a delay in post-Brexit rules that would add…
My coverage on Nvidia Corporation (NASDAQ:NVDA) as an AI (artificial intelligence) leader began in 2018…
Members of the Sackler family who own Purdue Pharma can be shielded from lawsuits linked…
The recent earning smash by NVIDIA (NVDA) has taken the investing world by storm. ChatGPT…
The largest eurozone lenders are exposed to “spillovers” of stress from outside the banking system,…
PTC Inc. (NASDAQ:PTC) delivered beneficial revenue growth and FCF expectations for the coming years. I…
UK prime minister Rishi Sunak will fly to Washington next week for a meeting with…
Introduction Intuit (NASDAQ:INTU) reported earnings last week, and the market did not like them much.…
Nvidia has become the first chipmaker to hit a $1tn valuation, leading a surge of…
Thesis and Background This is an update to an article we published on the REIT…
Spanish inflation has dropped to 2.9 per cent, its lowest level for almost two years,…
Investment Overview EyePoint Pharmaceuticals (NASDAQ:EYPT) is a Watertown, Massachusetts based ocular disease focused biotech whose…
YOUR EMAIL HAS BEEN CONFIRMED.
THANK YOU!
Sign in to your account